caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1801092705

Inderjit MehmiM.D.

Medical OncologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
8,431
Unique beneficiaries
—
Total services
44,494
Distinct HCPCS
57
Medicare payment
$1.8M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 268 Medical Oncology providers in CA — top quintile (cohort median 1,130).
PRESCRIBING · PART D · 2024
Total Rx claims
200
Beneficiaries
—
Total drug cost
$793K
Distinct drugs
8
Brand share
33.0%
Top prescribed drugs
Letrozole47 claims
Binimetinib29 claims
Prednisone28 claims
Encorafenib26 claims
Hydrocortisone24 claims
QUALITY · MIPS · 2024
Final MIPS score
89.1
Quality
84.8
Cost
73.2
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.60%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$23K
Payment records
36
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$13K
Honoraria$6K
Consulting Fee$2K
Travel and Lodging$2K
Food and Beverage$802